Phannacologic therapy following acute myocardial infarction
Abstract
The treatment after myocardial infarction depends on the patient risk. Daily aspirine
is advised for patients at low risk. There is also a growing tendency to prescribe an
"statine" in order to mantain the cholesterol level below 210 mg/dL. Estrogen therapy
can be considered in post-menopausal women. Beta-blocker agents have a proved benefIt
for patients at moderate risk because they reduce sudden death and reinfarction. Verapamil
is an option when the beta-blocker can not be tolerated. Treatment with ACE inhibitors
benefIt patients with left ventricular systolic dysfunction. Other pharmacologic agents are
of unproved benefIt - eg, nitrates- or have harrnful effects --eg, nifedipine, diltiazem
in patients with heart failure and cIass 1 antiarrhythmic drugs-. Only amiodarone seems
to be useful for patients with severe ventricular arryhthmias.
Downloads
References
Oxidation, inflarnmation, and genetics". Circulation (1995), 91:2488-2496.
MASERI, A., SEVERI, S., DE NES, M., et al.: "Variant" angina: one aspect of a
continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated
incidence and clinical and coronary angiographic findings in 138 patients". Am J Cardiol
(1978), 42:1019-1035.
FLUGELMAN, M. Y., VIRMANI, R., CORREA, R., et al.: "Smooth muscle cell abundance
and fibroblast growth factors in coronary lesions of patients with nonfatal unstable
angina: a clue to the mechanism of transformation from the stable to the unstable clinical
state". Circulation (1993), 88:2493-2500.
FALK, E.: "Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis:
characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi". Br
Heart J (1983), 50:127-134.
DA VIES, M. J., THOMAS, A. C.: "Plaque fissuring: the cause of acute myocardial
infarction, sudden ischemic death, and crescendo angina". Br Heart J (1985), 53:363-373.
FUSTER, V. BADIMON, L., COHEN, M., et al.: "Insights into the pathogenesis of acute
ischemic syndromes". Circulation (1988), 77:1213-1220.
FUSTER, V., STEIN, B., AMBROSE, J. A., et al.: "Atherosclerotic plaque rupture and
thrombosis. Evolving concepts". Circulation (1990), 82:ll47-ll59.
FUSTER, V., BADIMON, L., BADIMON, J. J., et al.: "The pathogenesis of coronary
artery disease and the acute coronary syndromes". N Engl J Med (1992), 326:242-250,
310-318.
GISSI GROUP (GRUPPO ITALIANO PER LO STUDIO DELLA STREPTOCHlNASI
NELL INFARTO MIOCARDICO): "Effectiveness of intravenous thrombolytic treatrnent
in acute myocardial infarction". Lancet (1986), i:397-402.
ISIS-2 (SECOND INTERNATIONAL STUDY OF INFARCT SURVIVAL) COLLABORATIVE
GROUP: "Randomised trial of intravenous streptokinase, oral aspirin, both, or
neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2". Lancet
(1988), ü:349-360.
THE GUSTO INVESTIGATORS: "An intemational randomized trial comparing four
thrombolytic strategies for acute myocardial infarction". N Engl J Med (1993), 329:673-
682.
TUSTALL-PEDOE, H., KUULASMAA, K., AMOUYEL, P., ARVEILER, D. ,
RAJAKANGAS, A. M., PAJAK, A.: "Myocardial infarction and coronary deaths in the
World Helath Organization MONICA project. Registration procedures, event rates, and
case-fatality rates in 38 populations from 21 countries in four continents". Circulation
(1994), 90:349-353.
STEVENSON, R. , RANJADA Y ALAN, K., WILKINSON, P., ROBERTS, R., TIMMIS,
A. D.: "Short and long term prognosis of acute myocardial infarction since introduction
of thrombolysis". Br Med J (1993), 307:349-353.
TAN, L. B., BALL, S. G.: "Principies of cardiac remodelling". In: ACE inhibition after
myocardial infarction (1994), pp. 15-27, Science Press, London.
PFEFFER, M. A., PFEFFER J. A., STEINBERG, c., FINN, P.: " Survival after experimental
myocardial infarction: beneficial effects of long-term therapy with captopril".
Circulation (1985), 72:406-412.
PFEFFER, M. A., BRAUNW ALD, E., MOYE, L. A., et al.: "Effect of captopril on
mortality and morbidity in patients with left ventricular dysfunction after acute myocardial
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
